| scholarly article | Q13442814 |
| P2093 | author name string | Dan Li | |
| Hong-Ying Chen | |||
| Xiao-Chun Chen | |||
| Xiao-Zhong Wang | |||
| Li-Juan Zhang | |||
| Zhi-Xin Chen | |||
| Feng-Lin Chen | |||
| Yun-Xin Chen | |||
| Qi-Ming Tao | |||
| P2860 | cites work | Regulation of Fas (CD95)-induced apoptosis by nuclear factor-KB and tumor necrosis factor- alpha in macrophages | Q23910429 |
| Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus | Q24292236 | ||
| Apoptosis by death factor | Q28304002 | ||
| Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis | Q28511080 | ||
| Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system | Q30724254 | ||
| Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways | Q33926143 | ||
| S gene variation of HBV. | Q33990286 | ||
| X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis | Q34234112 | ||
| Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins | Q34339787 | ||
| Hepatitis B virus X protein: a multifunctional viral regulator | Q34423640 | ||
| Hepatocellular carcinoma--cause, treatment and metastasis | Q34512068 | ||
| Molecular mechanism of viral hepatocarcinogenesis | Q34546003 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| TP53 and liver carcinogenesis. | Q35078725 | ||
| Expression of Fas ligand in liver metastases of human colonic adenocarcinomas | Q36186304 | ||
| Expression of IGF- II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/or HBV in tree shrews. | Q36492118 | ||
| Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma | Q36620123 | ||
| The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma | Q36621343 | ||
| Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. | Q39777499 | ||
| p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha | Q40688905 | ||
| Selective transcriptional regulations in the human liver cell by hepatitis B viral X protein | Q40876669 | ||
| Pro-apoptotic effect of the hepatitis B virus X gene. | Q40987754 | ||
| Countering the 'counterattack' hypothesis. | Q42409423 | ||
| In situ expression of Granzyme B and Fas-ligand in the liver of viral hepatitis | Q44052116 | ||
| Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma | Q45279592 | ||
| The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver | Q45733889 | ||
| A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival | Q45736695 | ||
| Direct binding of hepatitis B virus X protein and retinoid X receptor contributes to phosphoenolpyruvate carboxykinase gene transactivation | Q45740106 | ||
| Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. | Q45740494 | ||
| Hepatitis B virus X protein: searching for a role in hepatocarcinogenesis | Q45742254 | ||
| Expression of fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBX) in induction of Fas ligand | Q45748434 | ||
| Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. | Q45765264 | ||
| Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene | Q45770734 | ||
| HBx gene of hepatitis B virus induces liver cancer in transgenic mice | Q45852802 | ||
| Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. | Q46031717 | ||
| Resistance to Fas-mediated apoptosis in human hepatoma cells. | Q54162326 | ||
| Immune privilege or inflammation? Insights into the Fas ligand enigma | Q59881175 | ||
| Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC). | Q64882755 | ||
| Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? | Q71840957 | ||
| Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings | Q73816683 | ||
| Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells? | Q73911524 | ||
| Fas and fas ligand in human hepatocellular carcinoma | Q77095538 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 2671-2675 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system | |
| P478 | volume | 9 |
| Q46946895 | Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC |
| Q64227790 | HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles |
| Q84402966 | Immunopathology on hepatocyte expression of HBV surface, core, and x antigens in chronic hepatitis B: clinical and virological correlation |
| Q33248641 | Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice |
| Q36180409 | Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients |
| Q51965218 | Targeting drugs to combinations of receptors: a modeling analysis of potential specificity. |
| Q35136610 | The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma |
| Q33200560 | Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells |
Search more.